Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER

被引：0
|
作者：
Mitsuyoshi Takahara
Tomoya Mita
Naoto Katakami
Fumitaka Wada
Naru Morita
Yoko Kidani
Toshitaka Yajima
Iichiro Shimomura
Hirotaka Watada
机构：
[1] Osaka University,Department of Diabetes Care Medicine, Graduate School of Medicine
[2] Juntendo University Graduate School of Medicine,Department of Metabolism and Endocrinology
[3] Osaka University,Department of Metabolic Medicine, Graduate School of Medicine
[4] AstraZeneca K.K.,Medical Affairs
来源：
Diabetes Therapy | 2022年 / 13卷
关键词：
Antidiabetic drugs; Diabetes complications; Glycaemic control; Second-line treatment; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：251 / 264
页数：13
相关论文
共 50 条
  • [31] The relationship between renal function and diabetic retinopathy in patients with type 2 diabetes: A three-year prospective study
    Wang, Dongning
    Fan, Kaiwei
    He, Zhanpeng
    Guo, Xiao
    Gong, Xia
    Xiong, Kun
    Wei, Daheng
    Chen, Bingbing
    Kong, Fanxiao
    Liao, Mochong
    Wang, Wei
    Huang, Wenyong
    Liu, Hua
    Guangzhou Diabet Eye Study Grp
    HELIYON, 2023, 9 (04)
  • [32] Treatment Patterns and Associated Clinical Outcomes in Type 2 Diabetes Patients Initiating Second-Line Glucose-Lowering Therapy: Interim Analysis of Baseline Data from Turkey Arm of the Global DISCOVER Study
    Bayram, Fahri
    Sari, Ramazan
    Kucukler, Ferit Kerim
    Araz, Mustafa
    Colak, Ramis
    Baspinar, Osman
    Kucukardali, Yasar
    Calan, Mehmet
    Yilmaz, Ceren
    Utebay, Onur
    Tetiker, Tamer
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2021, 25 (02) : 202 - 215
  • [33] Effectiveness of Second-Line Agents in the Treatment of Uncomplicated Type 2 Diabetes Mellitus: An Observational Tertiary-Care Based Study
    Gill, Rupam
    Adiga, Shalini
    Varma, Muralidhar
    JOURNAL OF YOUNG PHARMACISTS, 2018, 10 (03) : 334 - 339
  • [34] Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study
    Nicolucci, Antonio
    Chen, Hungta
    Cooper, Andrew
    Fenici, Peter
    Gomes, Marilia B.
    Hammar, Niklas
    Ji, Linong
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Medin, Jennie
    Shestakova, Marina, V
    Shimomura, Iichiro
    Tang, Fengming
    Vora, Jiten
    Watada, Hirotaka
    Arnold, Suzanne, V
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 185
  • [35] A Three Year Cohort Prospective Type 2 Diabetes Control Study in Basrah
    Mansour, Abbas Ali
    Wanoose, Hameed Laftah
    Odaa, Akream Hussain
    JOURNAL OF DIABETES & METABOLISM, 2011, 2 (02)
  • [36] Long-term sustainability of glycaemic achievements with second-line antidiabetic therapies in patients with type 2 diabetes: A real-world study
    Montvida, Olga
    Shaw, Jonathan E.
    Blonde, Lawrence
    Paul, Sanjoy K.
    DIABETES OBESITY & METABOLISM, 2018, 20 (07): : 1722 - 1731
  • [37] Second-Line Therapy for Type 2 Diabetes Management: The Treatment/Benefit Paradox of Cardiovascular and Kidney Comorbidities
    McCoy, Rozalina G.
    Van Houten, Holly K.
    Karaca-Mandic, Pinar
    Ross, Joseph S.
    Montori, Victor M.
    Shah, Nilay D.
    DIABETES CARE, 2021, 44 (10) : 2302 - 2311
  • [38] Bariatric Surgery in Patients with Type 1 Diabetes and Obesity-A Three-Year Observational Matched Cohort Study
    Mottalib, Adham
    Alsibai, Khaled
    Tomah, Shaheen
    Elseaidy, Taha
    Holley-Cuthrell, Jenan R.
    Middelbeek, Roeland
    Mahmoud, Noor
    Ashrafzadeh, Sahar
    Brown, Florence M.
    Hamdy, Osama
    DIABETES, 2018, 67
  • [39] Proportion of patients reaching HbA1c targets related to second-line treatment initiation: a Nordic observational study comparing type 2 diabetes management in primary care
    Persson, F.
    Bodegard, J.
    Knudsen, S. T.
    Gulseth, H. L.
    Furuseth, K.
    Thuresson, M.
    Lindh, A.
    Alvarsson, M.
    Jorgensen, M. E.
    Sondergaard, J.
    Birkeland, K. I.
    Nilsson, P. M.
    DIABETOLOGIA, 2018, 61 : S176 - S177
  • [40] Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study
    Mamza, Jil
    Mehta, Rajnikant
    Donnelly, Richard
    Idris, Iskandar
    ANNALS OF MEDICINE, 2016, 48 (04) : 224 - 234
12345